Pratique du Shadowing: Breast Pathology Cases 3 and 4 - Apprendre l'anglais à l'oral avec la vidéo
Choisissez un mode d'entraînement
Chaque mode ouvre une salle d'entraînement en plein écran.
160 phrases
Si les phrases sont trop courtes ou trop longues, cliquez sur Edit pour les ajuster.
1
This is breast pathology cases 3 and 4.
2
This is a biopsy that was done for calcifications and from low magnification you can see we have multiple duct profiles that are being filled in by epithelial cells.
3
So let's take a closer look.
4
Closer inspection of this single duct shows that it's filled in by a population of atypical cells that are forming this cribriform architectural pattern.
5
Notice that these punched out spaces are relatively round and uniform and there is polarization of cells around the punched out spaces.
6
Here is a closer view of these cribriform structures.
7
Again, most of them are nice and round and uniform.
8
And lining these cribriform structures, you have a population of atypical cells with pleomorphic nuclei, hyperchromasia, pseudoinclusions, which is not a typical finding here.
9
But in general, lack of big prominent nucleoli.
10
There may be a few nucleoli in here, but for the most part, I would say it's relatively low to intermediate in its nuclear grade.
11
Let's step out one magnification and refer back to our previous case where we looked at a case of atypical
12
ductal hyperplasia and we said one of the key characteristics was basically partial duct involvement or involvement of a single duct profile.
13
Here we have, for the most part, most of these are complete duct involvement, meaning there's no residual normal ductal epithelium, no areas that look like usual ductal hyperplasia.
14
So we have a full duct profile here and we have several others that are fully involved as well.
15
So we have full duct involvement and multiple profiles that are involved.
16
So this meets criteria for ductal carcinoma in situ.
17
Then it comes down to really two things when you're dealing with ductal carcinoma in situ.
18
What is the nuclear grade and is there comedonecrosis?
19
There are various different subtypes of DCIS, and for the most part they're not important clinically.
20
What does matter is nuclear grade and presence or absence of comedonecrosis.
21
What you'll find with many cases of DCIS is you really have a spectrum of nuclear grade.
22
And in this particular case, I would say that most of the cells that we're seeing are relatively small and uniform.
23
We're not seeing a lot of nuclear membrane irregularities.
24
We're not seeing macronucleoli.
25
So I would call these low grade.
26
And then we have cells like this.
27
They're larger, they're a little more pleomorphic.
28
We have evacuated chromatin pattern and a lot of nuclear folds or nuclear membrane irregularities.
29
So in this particular case, I would call it ductal carcinoma in situ, low to intermediate nuclear grade.
30
And although I haven't shown the whole case, there was no comedonecrosis.
31
This is case four, which is also a biopsy done for calcifications.
32
And in this single focus, you can see that we have one, two, three, and maybe even four duct profiles involved by an intraductal proliferation.
33
Now it's clear from low power that for most people who are experienced what this is going to be, but let's walk through this systematically.
34
So we have an intraductal proliferation.
35
Is this invasive?
36
No.
37
Why?
38
It has rounded profiles, number one, and there's no desmoplasia.
39
Now there's a slight stromal reaction here, but it doesn't have an infiltrative pattern to it, and it's not pushing into the fat.
40
So we're dealing with an intraductal proliferation.
41
We had mentioned in our previous discussion that the general differential is between usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ.
42
So let's look closer at one of these duct profiles.
43
Here is a closer view showing several things.
44
First, there is a full duct involvement by this intraductal proliferation.
45
There is no residual normal duct epithelium and no areas that look like usual ductal hyperplasia, but let's explain why it's not usual ductal hyperplasia.
46
Remember that when we talked about usual ductal hyperplasia, we said that there was an intraductal proliferation that filled the lumen, and it was generally a disorderly arrangement as it moved into the lumen.
47
And in most cases of usual ductal hyperplasia, the cells get smaller as they move into the lumen.
48
Now you may say these cells look small, but this whole region here is all necrosis.
49
So let's ignore this for a moment and look at the viable cells.
50
So what do you see?
51
You see relative uniformity in the sense that they all look like a similar cell population, although there is pleomorphism.
52
Some are larger, some are smaller.
53
What do you see in terms of nuclear morphology?
54
Well, number one, the nuclei are enlarged.
55
The chromatin pattern is somewhat even although we do have some small nucleolite that are beginning to form.
56
There's abundant cytoplasm and there are conspicuous cell membranes.
57
There's even a mitotic figure here.
58
As they move into the lumen they become necrotic, so we have central necrosis.
59
And notice that the necrosis pushes on the epithelium and compresses it.
60
In other words it causes architectural change to the surrounding epithelium.
61
This is referred to as comedonecrosis.
62
So we have here ductal carcinoma in situ based on full duct involvement, based on multiple duct profiles, and also because we have a higher nuclear grade.
63
Let's look closer at some of these nuclei.
64
Here is a high magnification view of these cells.
65
So first of all, they are ductal epithelial in origin.
66
And you can tell that because you can make out the cell membranes and the cohesive nature of the epithelial cells.
67
When you're dealing with lobular neoplasia, either LCIS, which is lobular carcinoma in situ, or atypical lobular hyperplasia, one of its key characteristics is the lack of cellular cohesion, so it becomes more discohesive.
68
Here we have a cohesive process where you can make out cell membranes, abundant cytoplasm, And again, we have pleomorphic nuclei, some binucleation.
69
You can make out some notching and nuclear membrane irregularities.
70
The diagnosis for case 3 is ductal carcinoma in situ, low to intermediate grade.
71
The diagnosis for case 4 is ductal carcinoma in situ, high grade.
72
And you would also mention the presence of comedonecrosis.
73
Ductal carcinoma in situ is a neoplastic proliferation of ductal epithelial cells that is confined to the ductal or lobular system,
74
basically referring to the fact that it does not extend beyond the basement membranes and it retains an intact myoepithelial cell layer.
75
So if you were to use myoepithelial stains such as smooth muscle myosin, calponin, and you would see that these lesions would have an intact myopithelial cell layer.
76
These most commonly present as mammographic calcifications, and they have many different growth patterns that are described, many different subtypes that are described,
77
but as I had mentioned, the most important factors are nuclear grade, be it low grade, intermediate grade, or high grade,
78
and the presence or absence of comedonecrosis, which is a central type of necrosis that has architectural changes to the surrounding epithelium.
79
So it has a sort of compressive effect on the surrounding epithelium.
80
So we're going to go through a couple examples of DCIS and you need to name the type of DCIS.
81
This type would be cribriform because of its prominent cribriform architecture.
82
The next type would be solid.
83
Here it lacks the cribriform architecture although you can see a little bit over here, The solid type is essentially where you get a uniform proliferation of atypical cells within the lumen that lack any sort of cribriform architecture.
84
Here's an example of DCIS.
85
It's filling in the lumen, but even from low magnification, you can make out these fibrovascular cores.
86
It has a rounded border, so it's non-infiltrative.
87
There's no desmoplasia.
88
So this is DCIS of the papillary type.
89
What about this one?
90
Notice here we have atypical or malignant appearing epithelial cells filling in partially into the lumen, making these papillary-like structures, but they lack fibrovascular cores.
91
This is micropapillary DCIS.
92
What about this pattern?
93
Here we have central necrosis that's expanding and compressing the surrounding epithelium.
94
So this would be comedotype DCIS.
95
So with ductal carcinoma in situ, what to document?
96
You need to document nuclear grade, low, intermediate, or high.
97
And it's not uncommon to see a spectrum, so you can report low to intermediate or intermediate to high.
98
And then you need to document the presence and type of necrosis.
99
The most important type is that pattern that we saw, which is central with expansile features, which is called comedonecrosis.
100
But you can also see punctate central necrosis that has no impact on the surrounding epithelium.
101
And then you can report architectural patterns, although they are of less clinical significance.
102
Here's an example of low-grade DCIS.
103
You can see the relative uniformity of the cells that are filling in the lumen.
104
They're not all that different than the ADH type nuclei that we had seen in the previous case except that it's full duct involvement and it's multiple ducts involved.
105
Notice that the nuclei are round, they're monotonous, and the nucleoli are inconspicuous.
106
Now it's hard to tell from this power, but in general you're not going to see prominent macronucleoli.
107
You may find mitotic activity, but generally it's not going to be as frequent as you'll see in the higher grades of DCIS.
108
Here's another example of ductal carcinoma in situ of the micropapillary type, low nuclear grade.
109
Here's an example of high grade DCIS.
110
This would be of the comedotype, so we have central necrosis that has an expansile appearance to it.
111
We have markedly atypical nuclei, prominent nuclei, mitotic activity.
112
This is high-grade DCIS.
113
Here's another example of high-grade DCIS.
114
This is one that is known as the clinging type, where you have essentially a single layer of malignant-appearing cells.
115
In this particular case, we have some central necrosis.
116
Here's an example of intermediate grade DCIS.
117
We have mild to moderate nuclear pleomorphism, and the nucleoli are variably conspicuous.
118
Question, which of the following statements regarding low grade DCIS is false?
119
So let's just go through each one and say true or false.
120
Low-grade DCIS typically shows strong and diffuse expression of ER and PR.
121
True.
122
Low-grade DCIS typically has a low proliferative rate by KI-67.
123
True.
124
Low-grade DCIS typically lacks expression of cytokeratin 5-6.
125
True.
126
So you can exclude this one.
127
They do not typically have HER2 overexpression.
128
Now you should not, there's two things I would note here.
129
On all cases of DCIS, you're going to order estrogen and progesterone receptor.
130
There's no need to order a KI-67 and there's no reason to order HER2.
131
But you will find if you do have cases of invasive ductal carcinoma in which HER2 is ordered that it's not uncommon for it to be overexpressed in cases of high-grade DCIS, but generally it's going to be negative in cases of low-grade DCIS.
132
Question, what immunohistochemical stain is the most clinically relevant for DCIS?
133
Answer, estrogen receptor.
134
So tamoxifen significantly reduces the risk of local recurrence in patients with ER-positive DCIS.
135
So ER is important.
136
Question.
137
Which of the following features is associated with local recurrence following breast conserving treatment for DCIS?
138
You may pick more than one.
139
Answer.
140
All of these features.
141
So high nuclear grade, presence of comedor necrosis, a young patient age, less than 45 years, a large lesional size, and a positive margin are all associated with increased risk of local recurrence.
142
The most important among these is positive margin.
143
With respect to recurrence, around half of cases are DCIS and the other half are invasive carcinoma.
144
You make the diagnosis of low-grade DCIS on a needle core biopsy.
145
To what degree is this patient's risk elevated for developing invasive carcinoma?
146
Eight to tenfold.
147
What breast site is at risk?
148
Is it ipsilateral, contralateral, or bilateral?
149
Ipsilateral.
150
So to summarize, low-grade DCIS, 8 to 10-fold increased risk of developing invasive carcinoma, with the greatest risk being the ipsilateral breast.
151
So to summarize, we had said in the previous case that atypical ductal hyperplasia is associated with a 3-5 fold increased risk of developing invasive carcinoma.
152
With low-grade DCIS, it's elevated beyond that, it's 8-10 fold.
153
We mentioned that with atypical ductal hyperplasia, the risk was bilateral.
154
With low-grade DCIS, it puts greater risk on the side of the DCIS.
155
The treatment for atypical ductal hyperplasia is watching the patient, number one, and the and potentially tamoxifen to help reduce the risk.
156
For patients with low-grade DCIS on a needle core biopsy, the DCIS has to be surgically eradicated.
157
So there needs to be a resection with a negative margin.
158
And generally speaking, for a pathologist, a negative margin means it's not at ink.
159
But for DCIS, it needs to be beyond 2 millimeters.
160
So this completes cases 3 and 4.
Télécharger l'application
Tout pour parler couramment
Prononciation IAChaque phrase notée
Phonétique (IPA)Maîtrisez chaque son
VocabulaireEnrichissez votre lexique
Jeu de vocabulaireApprenez en jouant
Même chaîne
FOR YOU
Vidéo recommandée
C11
69 phrases
Spay/Neuter Patient Care: Patient Prep - Feline
Business EnglishUniversity StudentsWorking Adults
C11
91 phrases
How To: Ultrasound for Pneumothorax Case Study Video
Daily ConversationUniversity StudentsWorking Adults
C11
506 phrases
Analyzing Statements of Cash Flows 1 (2025 CFA® Level I Exam – FSA – Learning Module 4)
Business EnglishUniversity StudentsWorking Adults
C11
154 phrases
Sequential, Multiple Assignment, Randomized Trial Designs With Dr Kidwell
Daily ConversationUniversity StudentsWorking Adults
C21
148 phrases
Accurately Diagnosing the Soft Tissue Sarcoma
University StudentsWorking Adults
C23
29 phrases
Introduction to focused ion beam scanning electron microscopy (FIB-SEM)
University StudentsWorking Adults
C12
56 phrases
Intracranial Angioplasty | Dr. Sukalyan Purkayastha | Brain Mechanic
Daily ConversationUniversity StudentsWorking Adults
C12
111 phrases
2025 Pathology Review: Practical Updates in Breast, Gastrointestinal and Genitourinary Pathology
Business EnglishUniversity StudentsWorking Adults
C13
131 phrases
Understanding BGA Pads: Solder Mask Defined vs Non-Defined
Business EnglishUniversity StudentsWorking Adults
C17
31 phrases
SUMMARIZE SPOKEN TEXT - DNA & RNA
IELTS PrepTOEFL PrepUniversity Students
Vocabulaire et conseils d’expression pour cette leçon
Cette leçon d’expression orale de niveau C2 s’appuie sur la vidéo « Breast Pathology Cases 3 and 4 ». Les mots qui reviennent le plus souvent : Dcis, grade, ductal, cell, carcinoma. Cette vidéo contient 160 phrases et 2129 mots à répéter en shadowing. La partie parlée dure 16:16. Le locuteur parle à un rythme régulier d’environ 131 mots par minute, confortable pour le shadowing. Seuls 75 % des mots font partie des 3 000 mots les plus courants en anglais, le vocabulaire est donc exigeant.
Vocabulaire clé de cette vidéo
Les 15 mots les plus avancés de la vidéo, avec leur prononciation et leur sens :
| Mot | Prononciation | Sens |
|---|---|---|
| ductal adjectif | /ˈdʌktəl/ | ductal, canalaire |
| carcinoma nom | /ˌkɑɹsɪˈnoʊmə/ | carcinome |
| duct nom | /dʌkt/ | tuyau, conduit |
| hyperplasia nom | /ˌhaɪ.pɚˈpleɪ.ʒə/ | hyperplasie |
| atypical adjectif | /eɪˈtɪp.ɪ.kəl/ | atypique |
| necrosis nom | /nɛˈkɹoʊ.sɪs/ | nécrose |
| epithelium nom | /ˌɛpɪˈθiːlɪəm/ | épithélium |
| lumen nom | /ˈlumən/ | lumen |
| nucleus nom | /ˈnuː.kli.əs/ | noyau |
| intermediate adjectif | /ɪn.tə(ɹ)ˈmi.di.ət/ | intermédiaire |
| proliferation nom | /pɹəˌlɪf.əˈɹeɪ.ʃən/ | prolifération |
| invasive adjectif | /ɪnˈveɪsɪv/ | d'invasion |
| epithelial adjectif | épithélial | |
| surround verbe | /səˈɹaʊnd/ | entourer, cerner |
| biopsy nom | /ˈbaɪɑpsi/ | biopsie |
Les verbes à particule que vous entendrez
| Mot | Prononciation | Sens |
|---|---|---|
| make out verbe | /meɪk aʊt/ | libeller |
| go through verbe | traverser |
Des phrases à répéter
Des phrases courtes et complètes de la vidéo, à réutiliser dans la conversation de tous les jours :
- We're not seeing a lot of nuclear membrane irregularities.
- What do you see in terms of nuclear morphology?
- Let's look closer at some of these nuclei.
La grammaire de cette vidéo
Les structures que le locuteur utilise le plus, avec les mots exacts de la vidéo :
| Structure | Dans la vidéo |
|---|---|
| Voix passive be + participe passé — l’accent est mis sur ce qui arrive, pas sur qui le fait | are fully involved · are involved · are enlarged |
| Propositions relatives who / which + proposition — une précision sur une personne ou une chose | pseudoinclusions, which is · four, which is · people who are |
| Present perfect have/has + participe passé — une action passée qui compte encore maintenant | have evacuated · haven't shown · has rounded |
Prononciation à surveiller
Le locuteur utilise 18 contractions et formes réduites, comme they're, we're, you're. Prononcez-les sous leur forme courte, telles que vous les entendez.
- Les sons « th »: epithelium /ˌɛpɪˈθiːlɪəm/, pathology /pəˈθɒləd͡ʒi/
- Les sons « sh » et « zh »: hyperplasia /ˌhaɪ.pɚˈpleɪ.ʒə/, proliferation /pɹəˌlɪf.əˈɹeɪ.ʃən/, magnification /ˌmæɡnɪfɪˈkeɪʃən/, calcification /ˌkælsɪfɪˈkeɪʃən/, cohesion /kəʊˈhiː.ʒən/
- Mots longs — placez bien l’accent: carcinoma /ˌkɑɹsɪˈnoʊmə/, hyperplasia /ˌhaɪ.pɚˈpleɪ.ʒə/, atypical /eɪˈtɪp.ɪ.kəl/, epithelium /ˌɛpɪˈθiːlɪəm/, intermediate /ɪn.tə(ɹ)ˈmi.di.ət/
Les sons difficiles pour les francophones :
- /h/ — il se souffle, il n’est pas muet: hyperplasia /ˌhaɪ.pɚˈpleɪ.ʒə/, cohesive /kəʊˈhiː.sɪv/, cohesion /kəʊˈhiː.ʒən/
- /tʃ/ et /dʒ/ — à ne pas adoucir en « ch » et « j »: architectural /ˌɑɹkɪˈtɛkt͡ʃəɹəl/, estrogen /ˈɛstɹəd͡ʒən/, residual /ɹɪˈzɪd͡ʒ.u.əl/, enlarge /ɪnˈlɑɹd͡ʒ/, morphology /mɔɹˈfɑ.lə.d͡ʒi/
- /r/ anglais — langue recourbée, sans frotter la gorge: carcinoma /ˌkɑɹsɪˈnoʊmə/, necrosis /nɛˈkɹoʊ.sɪs/, intermediate /ɪn.tə(ɹ)ˈmi.di.ət/, proliferation /pɹəˌlɪf.əˈɹeɪ.ʃən/, surround /səˈɹaʊnd/
Comment s’entraîner avec cette vidéo
- Écoutez la vidéo en entier une fois sans parler et notez les mots que vous ne connaissez pas.
- Répétez phrase par phrase à vitesse normale, en reprenant chacune jusqu’à ce que votre rythme corresponde à celui du locuteur.
- Enregistrez-vous et comparez avec l’original, en faisant attention à des mots comme ductal, carcinoma, duct.
Qu'est-ce que la technique du Shadowing ?
Le Shadowing est une technique d'apprentissage des langues fondée sur la science, développée à l'origine pour la formation des interprètes professionnels. Le principe est simple mais puissant : vous écoutez de l'anglais natif et le répétez immédiatement à voix haute — comme une ombre suivant le locuteur avec un décalage de 1 à 2 secondes. Les recherches montrent une amélioration significative de la précision de la prononciation, de l'intonation, du rythme, des liaisons, de la compréhension orale et de la fluidité.